Clinical Trial Update: Reduction of Occurence of Acute Kidney Injury (AKI) Through Administration of Glutamine [Phase 3]

View source ↗

Summary

Phase 3 trial investigating glutamine to reduce occurrence of acute kidney injury in cardiac surgery patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiac Surgery-related Acute Kidney Injury

Drugs mentioned

• Glutamine (glutamine)

Snippet

Sponsor: University Hospital Muenster | Conditions: Cardiac Surgery, Acute Kidney Injury | Phase 3 | Status: COMPLETED